COSMOS HEALTH INC.

COSM

CIK 0001474167 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$20M
↑+38.5% +$5Mvs FY2024 (Q4)
Operating Income
$1M
↑+718.1% +$1Mvs FY2024 (Q4)
Net Income
$699K
Gross Profit
$2M
↑+107.2% +$1Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
64/100
  • Profitability
    0ROIC -51.9% (10% = solid, 20%+ = moat)
  • Liquidity
    25Current Ratio 1.00 (above 1.5 = solid)
  • Leverage
    90D/E 0.20 (under 0.5 = conservative)
  • Efficiency
    68Asset Turnover 1.09x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +38.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -10.6% · trend +5.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$56K
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$2M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$65M
everything owned
Total liabilities
$47M
everything owed
Stockholders' equity
$18M
shareholder claim
Net debt
$3M
LT debt minus cash

Recent performance · 65 quarters

Revenue↑+38.5% +$5M
$20M
Net Income↑+36.1% +$3M
$-5M
Free Cash Flow↑+89.1% +$65K
$-8K
Operating Margin↑+7.4pts
-10.6%

Drill down